For its lifesaving care of patients with severely injured hearts and lungs, University of Virginia Medical Center has earned the Extracorporeal Life Support Organization’s Platinum Level Center of Excellence Award, the international group’s highest honor. Fewer than 30 hospitals worldwide have earned this award.
A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world’s smallest, flexible scope for looking inside blood vessels.
While some hospitals paused or reduced organ transplants, MedStar Heart & Vascular Institute at MedStar Washington Hospital Center performed a record number of heart transplants during the height of the COVID-19 pandemic. Between March and May, 13 patients received new hearts–-more than double MedStar Heart & Vascular Institute’s typical volumes.
In an article published online on June 26 in the journal Heart Rhythm, lead author Raul Mitrani, M.D., and co-authors with the University of Miami Miller School of Medicine’s Division of Cardiovascular Medicine, examine the varied cardiovascular injuries and complications that patients who have recovered from the acute COVID-19 infection may experience largely based on evidence from other viral infections or inflammatory injury to the heart. The authors also recommend developing screening and tracking measures to detect cardiac injury and potentially mitigate long-term impact.
When seeking critical medical care, minutes count — especially when dealing with cases of suspected heart attack or stroke. Yet many patients in need of emergency care have delayed or avoided a trip to the hospital fearing possible infection with COVID-19.
Researchers have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available. A new study published in the journal Science Translational Medicine describes the drug and its delivery mechanisms and shows that the drug is also an effective treatment for heart attack in animal models.
In a groundbreaking new study, researchers at the University of Minnesota have 3D printed a functioning centimeter-scale human heart pump in the lab. The discovery could have major implications for studying heart disease, the leading cause of death in the United States killing more than 600,000 people a year.
• Ensures close connection between patient and physician for remote hypertension monitoring
• Complements Mount Sinai’s growing telehealth initiative
• Medicare-covered and generally at no cost to patients, depending on coverage
A drug used to treat systemic lupus erythematosus (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows.
A compound commonly found in pickled capers has been shown to activate proteins required for normal human brain and heart activity, and may even lead to future therapies for the treatment of epilepsy and abnormal heart rhythms.
An expert medical task force appointed by the American Medical Society for Sports Medicine (AMSSM) and National Federation of State High School Associations (NFHS) has issued guidance for assessing potential cardiac issues in high school student-athletes with COVID-19 infection.
Cleveland Clinic researchers have found a significant increase in patients experiencing stress cardiomyopathy, also known as broken heart syndrome, during the COVID-19 pandemic.
Current research indicates that unhealthy lifestyle choices along with emotional stressors like social are important risk factors for developing upper respiratory infections. It is possible these same factors also increase the risk of contracting COVID-19.
Young firefighter recruits who follow a ‘Mediterranean lifestyle’ are less likely to have hypertension (high blood pressure) and more likely to have good aerobic fitness, reports a study in the July Journal of Occupational and Environmental Medicine.
Scientists have discovered that one of the good bacteria found in the human gut has a benefit that has remained unrecognized until now: the potential to reduce the risk for heart disease.
A new COVID-19 Heart Program developed by cardiologists with the University of Miami Miller School of Medicine is addressing the varied heart issues stemming from the pandemic with comprehensive screenings and evaluations in a safe clinical setting. It also incorporates the latest findings from UM cardiology researchers studying how the coronavirus can affect the heart and its surrounding tissues.
New UCLA research conducted in mice could explain why some people suffer more extensive scarring than others after a heart attack. The study, published in the journal Cell, reveals that a protein known as type 5 collagen plays a critical role in regulating the size of scar tissue in the heart.
High-risk drinkers who substantially reduce their alcohol use can lower their risk of cardiovascular disease (CVD) despite not completely abstaining, according to study findings published in Alcoholism: Clinical and Experimental Research. CVD encompasses a range of conditions involving the heart or blood vessels, and is the leading cause of death in the US. It is also one of many negative health outcomes associated with heavy drinking and alcohol use disorder (AUD). Reductions in drinking can be defined using World Health Organization (WHO) ‘risk drinking levels’, which classify drinkers into ‘very high’, ‘high’, ‘moderate’ and ‘low’ risk categories based on their average daily alcohol consumption. Previous research has shown that a reduction of two or more levels (for example, from ‘very high’ to ‘moderate’) can lower the risk of multiple health issues, but did not assess the impact on CVD specifically. The latest study has examined associations between reductions in WHO risk drinking
New research from The University of Queensland has found that women who have hot flushes and night sweats after menopause are 70 per cent more likely to have heart attacks, angina and strokes.
A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus. The discovery, published today in the journal Cell Reports Medicine, was made using heart muscle cells that were produced by stem cell technology.
DALLAS – July 1, 2020 – A new report from cardiologists at UT Southwestern raises the hope that doctors will be able to visually check the jugular venous pressure of heart failure patients remotely, using the camera on a smartphone. The finding is especially timely as telemedicine expands during the pandemic.
After being defunded by a company with rights to its intellectual property, development of a pediatric heart-assist device has been revived at Cornell with the help of a $4.7 million grant from the U.S. Department of Defense.
MacNeal Hospital is the first hospital in Illinois to participate in a national, randomized clinical trial using daily vital signs and lung pressure measurement to manage patients with congestive heart failure (CHF). The PROACTIVE-HF trial utilizes a new monitoring system, coupled with a pressure sensor, implanted directly into a blood vessel in the lung. This system provides information that is recorded and transmitted over a cellular or Wi-Fi connection to a patient’s provider, allowing for medication changes, if necessary, to prevent further health deterioration or hospitalization.
Heart failure posed the greatest 5-year risk of death for people newly diagnosed with Type 2 diabetes than any other heart or kidney diseases, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Microorganisms on the tongue could help diagnose heart failure, according to research presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC).1
Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalized COVID-19 patients to suffer cardiac arrest or heart rhythm disorders, according to a new study. .
DALLAS – June 22, 2020 – For decades, high-density lipoprotein (HDL) cholesterol has been dubbed “good cholesterol” because of its role in moving fats and other cholesterol molecules out of artery walls. People with higher HDL cholesterol levels tend to have lower rates of cardiovascular disease, studies have shown.
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.
As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.
Nearly 10 percent of patients who are prescribed opioid medications following heart surgery will continue to use opioids more than 90 days after the procedure, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.
Cholesterol levels are declining sharply in western nations, but rising in low- and middle-income nations - particularly in Asia, according to a study of global cholesterol levels, which involve researchers at the University of Gothenburg.
Scientists have discovered an important cell signalling pathway in the kidney which if stopped, could hold the key to treating chronic kidney disease as well as other deadly conditions, including heart attack and stroke.
Use the right tool for the job. Today experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders.
A new, multi-ethnic study from researchers at Tufts University and Tufts Medical Center found adults aged 54-76 with low circulating vitamin K levels were more likely to die within 13 years compared to those with adequate levels, suggesting vitamin K may offer protective health benefits as we age.
A newly published study of flies found that protecting liver function also preserves heart health. The research could lead to new therapeutic approaches in human health and illuminate the role of understudied organelles known as peroxisomes.
The national law requiring calorie labeling on menus at large chain restaurants is estimated to prevent tens of thousands of new heart disease and type 2 diabetes cases—and save thousands of lives—in just five years, according to a new study that estimates the law’s impact.
The Cardiovascular Research Foundation (CRF) announced that TVT Connect will feature eight studies as Late-Breaking Clinical Science. They will be presented during episodes moderated by the editors of Circulation: Cardiovascular Interventions and JACC: Cardiovascular Interventions. Each late-breaking science episode will host a live wrap-up and Q&A session afterwards.
Analysis of Seattle emergency medical services (EMS) and hospital data from January 1 to April 15, 2020, indicates bystander CPR is a lifesaving endeavor whose benefits outweigh the risks of COVID-19 infection, according to a new article published yesterday in the American Heart Association's flagship journal Circulation.
Disrupted nightly sleep and clogged arteries tend to sneak up on us as we age. And while both disorders may seem unrelated, a new study from the University of California, Berkeley, helps explain why they are, in fact, pathologically intertwined.
Women's risk of falling ill with cardiovascular disease, and dying from it, is lower than that of men of the same age, irrespective of where in the world they live.
The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for Covid-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system to observe exactly how the drug creates serious disturbances in the electrical signals that govern heartbeat.